Reuters logo
BRIEF-Recce Ltd updates on U.S. Food And Drug Administration grants
November 16, 2017 / 1:03 AM / a month ago

BRIEF-Recce Ltd updates on U.S. Food And Drug Administration grants

Nov 16 (Reuters) - Recce Ltd:

* ‍U.S. Food And Drug Administration has granted qualified infectious disease product designation for its lead compound Recce® 327​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below